Skip to content

Compare the effectiveness of betamethasone and lavender and peppermint in reducing the severity of symptoms in patients with eczema and psoriasis

Compare the effectiveness of betamethasone and lavender and peppermint in reducing the severity of symptoms in patients with eczema and psoriasis

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100420003760N4
Enrollment
120
Registered
2020-07-29
Start date
2017-01-19
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: eczema and psoriasis. Condition 2: Psoriasis. Dry skin dermatitis, Psoriasis, unspecified Dry skin dermatitis, Psoriasis, unspecified

Interventions

Intervention 1: Intervention group: receive the essential oil of Lavendula ooficinalis 3 % b.i.d Up to two weeks. Intervention 2: Intervention group: receive the essential oil of Lavendula ooficinali

Sponsors

Khoram-Abad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: The study population of men and women over the age of 10 with eczema or psoriasis who have been referred to the nomadic hospital since the beginning of the fall of 2016 for one year.

Exclusion criteria

Exclusion criteria: Patients who have had a corticosteroid injection or have taken other oral or topical medications will be excluded.

Design outcomes

Primary

MeasureTime frame
Scaly. Timepoint: 0,7,14. Method of measurement: Questionnaire.;Painful. Timepoint: 0,7,14. Method of measurement: Questionnaire.;Itching. Timepoint: 0,7,14. Method of measurement: Questionnaire.;Skin lesions. Timepoint: 0,7,14. Method of measurement: Questionnaire.;Swelling. Timepoint: 0,7,14. Method of measurement: Questionnaire.;Redness of the skin. Timepoint: 0,7,14. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Skin irritation. Timepoint: Days 1,7,14. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Rashidipour

Lorestan University of Medical Sciences

m_rashidi80@yahoo.com+98 66 3320 4005

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026